Medicine and Dentistry
Intravascular Ultrasound
100%
Coronary Artery Disease
96%
ST Segment Elevation Myocardial Infarction
86%
Percutaneous Coronary Intervention
84%
Low Density Lipoprotein Cholesterol
75%
Intravascular Imaging
64%
near Infrared Spectroscopy
62%
Myocardial Infarction
54%
Risk Stratification
51%
Cardiovascular Risk
44%
Statin
40%
Ischemia
38%
Ezetimibe
34%
Biological Marker
32%
Single-Photon Emission Computed Tomography
32%
Revascularization
32%
Neointima
32%
Treatment Planning
32%
Empagliflozin
32%
Intercellular Adhesion Molecule 1
32%
Carotid Artery Stenting
32%
Interventional Cardiology
32%
Combination Therapy
32%
Atrial Fibrillation
32%
Exome Sequencing
32%
Cardiovascular System
32%
Coronary Artery
32%
Gene Inactivation
32%
Apoplexy
32%
Drug-Eluting Stent
32%
Acute Coronary Syndrome
32%
Artery Lesion
27%
Plasminogen Activator Inhibitor-1
21%
Coronary Angiography
18%
Stenosis
18%
Patient with Type 2 Diabetes
16%
Vulnerable Plaque
16%
Atorvastatin
16%
Study Participant
16%
Infrared Spectroscopy
16%
Proprotein Convertase 9
16%
Low-Density Lipoprotein
16%
Heart Muscle Perfusion
14%
Atherosclerosis
12%
Infarction
10%
Prevalence
10%
Protective Factor
10%
Thrombosis
10%
Cardiac Magnetic Resonance Imaging
10%
Arm
10%
Pharmacology, Toxicology and Pharmaceutical Science
Coronary Artery Disease
88%
Cardiovascular Risk
72%
Low Density Lipoprotein Cholesterol
68%
Inclisiran
66%
ST Segment Elevation Myocardial Infarction
64%
Rosuvastatin
48%
Atorvastatin
48%
Statin (Protein)
46%
Ezetimibe
41%
Antihypertensive Agent
40%
Heart Infarction
37%
Biological Marker
37%
Hypolipemia
37%
Infrared Spectroscopy
36%
Antihypertensive Therapy
32%
Amlodipine
32%
Combination Therapy
32%
Cerebrovascular Accident
32%
Intercellular Adhesion Molecule 1
32%
Empagliflozin
32%
microRNA 155
32%
Circulating microRNA
32%
microRNA 126
27%
Fluspirilene
21%
Plasminogen Activator Inhibitor 1
21%
Prospective Study
20%
Non Insulin Dependent Diabetes Mellitus
19%
N Ethyl 2 [N (6 Methoxy 3 Pyridinyl) 2 Methylbenzenesulfonamido] N (3 Pyridinylmethyl)acetamide
16%
Prevalence
16%
Artery Lesion
16%
Stenosis
16%
Proprotein Convertase 9
16%
Low Density Lipoprotein
16%
microRNA
13%
Infarction
10%
All Cause Mortality
10%
Triacylglycerol
9%
C Peptide
9%
Clinical Study
8%
Carotid Artery Obstruction
8%
Antiplatelet
8%
Dipeptidyl Peptidase IV Inhibitor
8%
Comorbidity
8%
Congestive Heart Failure
8%
Atherosclerosis
7%
Ischemia
6%
Dyslipidemia
6%
Nursing and Health Professions
Coronary Artery Disease
48%
Patient Compliance
32%
Antihypertensive Agent
32%
Pilot Study
32%
Revascularization
32%
Treatment Planning
32%
Acute Coronary Syndrome
32%
Single-Photon Emission Computed Tomography
32%
Cardiovascular Risk
32%
Percutaneous Coronary Intervention
32%
Hypolipemia
32%
Inclisiran
32%
Systolic Blood Pressure
32%
Low Density Lipoprotein Cholesterol
32%
near Infrared Spectroscopy
32%
ST Segment Elevation Myocardial Infarction
32%
Blood Pressure
24%
Stenosis
18%
Rosuvastatin
16%
Lipid Composition
16%
Ezetimibe
16%
Infrared Spectroscopy
16%
Artery Lesion
16%
Proprotein Convertase 9
16%
Atorvastatin
16%
Study Participant
16%
Low Density Lipoprotein
16%
Statin (Protein)
16%
Perfusion
12%
Imaging
10%
Heart Left Ventricle Ejection Fraction
10%
Proportional Hazards Model
10%
All Cause Mortality
10%
Hazard Ratio
10%
University Hospital
8%
Prevalence
8%
Arterial Pressure
8%
Blood Pressure Monitor
8%
Angiography
7%
Dyslipidemia
6%
Ischemia
6%
Exercise Test
6%
Heart Muscle Perfusion
6%
